PH VACCINE PANEL CLEARS CHINA’S SINOVAC FOR CLINICAL TRIALS
According to Food and Drug Administration Director General Eric Domingo, the vaccine expert panel (VEP) under the Department of Science and Technology (DOST) has cleared China’s anti-COVID-19 vaccine Sinovac for clinical trials in the Philippines.
According to Domingo, VEP reviews Phase 1 and 2 clinical trials of the candidate vaccine, while the Ethics Board evaluates the selection for participants for clinical trials, among other safeguards that the vaccine manufacturer provided for the participants.
Domingo clarified that Sinovac, would still have to secure approval from the Ethics Board before it gets to apply for FDA clearance for the clinical trials.
“Meron na kaming hinihintay na mag-submit, kasi in-endorse na sa amin ng VEP. Iyong sa Sinovac,” Domingo said in an online forum.
Domingo said that Sinovac got VEP’s clearance last Monday.